Julia Talsma, Content Channel Director
Julia Talsma is lead editor for Drug Topics magazine.
Two long-acting insulins approved for diabetes mellitus
FDA has approved two long-acting insulins by Novo Nordisk for the treatment of adults with diabetes mellitus.
A road map to severe hypoglycemia reduction in hospital patients
How a large healthcare system in St. Louis, Mo., drove down the number of severe hypoglycemia cases in hospitalized patients over a five-year period.
New treatment approved for advanced colorectal cancer
FDA has approved a combination oral therapy of trifluridine and tipiracil (Lonsurf, Taiho Oncology) for patients with metastatic colorectal cancer who were previously treated with chemotherapy and biological therapy.
New treatment approved for bipolar disorder, schizophrenia
FDA has approved cariprazine (Vraylar) capsules, an atypical antipsychotic, indicated for the treatment of adults with schizophrenia as well as bipolar I disorder, based on controlled trials of more than 2,700 individuals.
New Clozapine REMS program changes monitoring, dispensing requirements
FDAhas announced new REMS requirements for clozapine, an atypical antipsychotic for treatment-resistant schizophrenia, noting continued risk of severe neutropenia.
Risk of neutropenia prompts new monitoring for antipsychotic drug
FDA announced new requirements for the monitoring, prescribing, and dispensing of clozapine, an atypical antipsychotic for treatment-resistant schizophrenia, due to the continued risk of severe neutropenia, which can be life-threatening.
New resources for independents help patients, pharmacies thrive
AmerisourceBergen amps up its tools for community pharmacies
New health app redefines pharmacist-patient relationship
New health app redefines pharmacist-patient relationship
With Spark Health, pharmacists can track patients' data, monitor their outcomes, and give them plenty of warm fuzzies, 21st-century-style.
First biosimilar in U.S. now available
Sandoz announced that Zarxio (filgrastim-sndz), the first biosimilar approved by the FDA in March, is now available in the United States.
Pharmacist-directed care for HIV patients provides earlier viral suppression
HIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician, according a report published in the September 1 issue of the American Journal of Health-System Pharmacy.